RFA
PPBT

Reilly Financial Advisors’s Purple Biotech PPBT Stock Holding History

Reilly Financial Advisors’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2
Closed -$1K – 1041
2020
Q4 		$1K Hold
2
– – ﹤0.01% 865
2020
Q3 		$2K Buy
+2
New +$2.47K ﹤0.01% 762
2020
Q2 		– Sell
-1
Closed -$1K – 949
2020
Q1 		$1K Buy
+1
New +$1.23K ﹤0.01% 850

Other funds holding PPBT

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WTB
Washington Trust Bank Spokane, Washington $1.36B AUM 21.14% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Reilly Financial Advisors's PPBT Position: Q1 2021 in Review

Reilly Financial Advisors sold out of Purple Biotech (PPBT) in Q1 2021, closing a stake of 2 shares — an estimated $1K sold.

Reilly Financial Advisors first reported a position in PPBT in Q1 2020 and held it in 3 quarters. The position peaked at $2K in Q3 2020. 15 funds tracked by Wall St. Rank hold PPBT as of Q1 2021.

  • Reilly Financial Advisors reported no remaining Purple Biotech position as of Q1 2021 after selling out during the quarter.
  • Reilly Financial Advisors sold 2 Purple Biotech shares in Q1 2021, an estimated $1K.
  • Reilly Financial Advisors first reported a position in Purple Biotech in Q1 2020 and held it in 3 quarters.
  • Reilly Financial Advisors's Purple Biotech position peaked at $2K in Q3 2020.
  • 15 funds tracked by Wall St. Rank held Purple Biotech as of Q1 2021.

Based on Reilly Financial Advisors's 13F filing for Q1 2021, filed 22 Apr 2021.